HK1198536A1 - New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor [12-c] - Google Patents

New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor [12-c]

Info

Publication number
HK1198536A1
HK1198536A1 HK14112037.4A HK14112037A HK1198536A1 HK 1198536 A1 HK1198536 A1 HK 1198536A1 HK 14112037 A HK14112037 A HK 14112037A HK 1198536 A1 HK1198536 A1 HK 1198536A1
Authority
HK
Hong Kong
Prior art keywords
dihydropyrrolo
imidazolyl
salts
new forms
aromatase inhibitor
Prior art date
Application number
HK14112037.4A
Other languages
English (en)
Chinese (zh)
Inventor
Paul Sutton
Eric Loeser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47604250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1198536(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1198536A1 publication Critical patent/HK1198536A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK14112037.4A 2012-01-17 2014-11-28 New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor [12-c] HK1198536A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261587280P 2012-01-17 2012-01-17
PCT/US2013/021521 WO2013109514A1 (en) 2012-01-17 2013-01-15 New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor

Publications (1)

Publication Number Publication Date
HK1198536A1 true HK1198536A1 (en) 2015-05-15

Family

ID=47604250

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112037.4A HK1198536A1 (en) 2012-01-17 2014-11-28 New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor [12-c]

Country Status (41)

Country Link
US (2) US9334276B2 (xx)
EP (1) EP2804863B1 (xx)
JP (1) JP5749410B2 (xx)
KR (2) KR20140093726A (xx)
CN (1) CN104039793B (xx)
AP (1) AP2014007762A0 (xx)
AR (1) AR089728A1 (xx)
AU (1) AU2013209952B2 (xx)
BR (1) BR112014017260A8 (xx)
CA (1) CA2863339C (xx)
CL (1) CL2014001863A1 (xx)
CO (1) CO7000775A2 (xx)
CR (1) CR20140345A (xx)
CU (1) CU20140086A7 (xx)
CY (1) CY1117914T1 (xx)
DK (1) DK2804863T3 (xx)
EA (1) EA026232B1 (xx)
ES (1) ES2564143T3 (xx)
GT (1) GT201400155A (xx)
HK (1) HK1198536A1 (xx)
HR (1) HRP20160178T1 (xx)
HU (1) HUE026984T2 (xx)
IL (1) IL233541B (xx)
IN (1) IN2014DN06781A (xx)
JO (1) JO3137B1 (xx)
MA (1) MA35858B1 (xx)
MX (1) MX2014008686A (xx)
NZ (1) NZ626277A (xx)
PE (1) PE20142358A1 (xx)
PH (1) PH12014501638A1 (xx)
PL (1) PL2804863T3 (xx)
RS (1) RS54589B1 (xx)
SG (1) SG11201404061YA (xx)
SI (1) SI2804863T1 (xx)
SM (1) SMT201600083B (xx)
TN (1) TN2014000256A1 (xx)
TW (1) TWI609869B (xx)
UA (1) UA114803C2 (xx)
UY (1) UY34576A (xx)
WO (1) WO2013109514A1 (xx)
ZA (1) ZA201404314B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5602250B2 (ja) * 2010-01-14 2014-10-08 ノバルティス アーゲー 副腎ホルモン修飾剤の使用
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
EA201991359A1 (ru) * 2014-07-07 2020-03-13 Новартис Аг Фармацевтические лекарственные формы
RS61908B1 (sr) * 2015-01-29 2021-06-30 Recordati Ag Postupak za proizvodnju kondenzovanih imidazolo derivata
US20160287565A1 (en) * 2015-04-06 2016-10-06 Millendo Therapeutics, Inc. Combination therapy for treating disorders associated with excess cortisol production
WO2018078049A1 (en) * 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
KR102506380B1 (ko) 2016-10-27 2023-03-03 다미안 파르마 에이쥐 알도스테론 합성효소 저해제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1315449A (en) * 1918-11-15 1919-09-09 Frank B Yingling Shaper-feed.
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5066656A (en) 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
MTP1076B (en) * 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate
DK0625155T3 (da) 1992-01-27 2001-11-12 Janssen Pharmaceutica Nv Pyrroloimidazolyl- og imidazopyridinyl-substituerede 1H-benzimidazolderivater som aromataseinhibitorer
ATE398124T1 (de) 2002-11-18 2008-07-15 Novartis Pharma Gmbh Imidazoä1,5üa pyridin-derivate und methoden zur behandlung von krankheiten in verbindung mit aldosteron
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
EP2094669A2 (en) 2006-12-18 2009-09-02 Novartis AG 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
EP2507234B1 (en) 2009-11-30 2014-03-12 Novartis AG Imidazole derivatives as aldosterone synthase inhibitors
JP5602250B2 (ja) * 2010-01-14 2014-10-08 ノバルティス アーゲー 副腎ホルモン修飾剤の使用

Also Published As

Publication number Publication date
SI2804863T1 (sl) 2016-05-31
TWI609869B (zh) 2018-01-01
PL2804863T3 (pl) 2016-06-30
CO7000775A2 (es) 2014-07-21
PE20142358A1 (es) 2015-01-30
CA2863339C (en) 2021-03-23
CY1117914T1 (el) 2017-05-17
ES2564143T3 (es) 2016-03-18
EP2804863B1 (en) 2015-12-02
GT201400155A (es) 2017-09-28
DK2804863T3 (en) 2016-03-07
AP2014007762A0 (en) 2014-07-31
MX2014008686A (es) 2014-08-27
BR112014017260A2 (pt) 2017-06-13
ZA201404314B (en) 2015-08-26
EA026232B1 (ru) 2017-03-31
SG11201404061YA (en) 2014-08-28
AU2013209952B2 (en) 2016-09-01
AR089728A1 (es) 2014-09-10
UA114803C2 (uk) 2017-08-10
HRP20160178T1 (hr) 2016-03-25
HUE026984T2 (en) 2016-08-29
SMT201600083B (it) 2016-04-29
JP5749410B2 (ja) 2015-07-15
IL233541B (en) 2018-12-31
IL233541A0 (en) 2014-08-31
ES2564143T8 (es) 2020-11-18
AU2013209952A1 (en) 2014-07-24
NZ626277A (en) 2015-10-30
RS54589B1 (en) 2016-08-31
TW201335161A (zh) 2013-09-01
BR112014017260A8 (pt) 2017-07-04
EA201491374A1 (ru) 2014-12-30
CA2863339A1 (en) 2013-07-25
CN104039793A (zh) 2014-09-10
TN2014000256A1 (en) 2015-09-30
CU20140086A7 (es) 2014-12-26
PH12014501638B1 (en) 2014-10-13
KR20140093726A (ko) 2014-07-28
CN104039793B (zh) 2017-05-10
UY34576A (es) 2013-09-02
CR20140345A (es) 2014-09-09
WO2013109514A1 (en) 2013-07-25
IN2014DN06781A (xx) 2015-05-22
MA35858B1 (fr) 2014-12-01
JO3137B1 (ar) 2017-09-20
CL2014001863A1 (es) 2014-11-07
KR20140141687A (ko) 2014-12-10
PH12014501638A1 (en) 2014-10-13
US20140364470A1 (en) 2014-12-11
EP2804863A1 (en) 2014-11-26
US20160176883A1 (en) 2016-06-23
US9334276B2 (en) 2016-05-10
JP2015503627A (ja) 2015-02-02

Similar Documents

Publication Publication Date Title
HK1204575A1 (en) Combinations of akt inhibitor compounds and abiraterone, and methods of use akt
HK1198536A1 (en) New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor [12-c]
ZA201208074B (en) At-bit evaluation of formation parameters and drilling parameters
HK1178149A1 (en) Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use -4---
EP2637502A4 (en) MUTANT-SELECTIVE EGFR HEMMER AND USES THEREOF
HRP20160735T1 (hr) Derivati tetrahidro-kinazolinona kao inhibitori tank i parp
ZA201206456B (en) Uses of dgati inhibitors
EP2701512A4 (en) INHIBITORS OF ALDOSTERONE SYNTHASE
EP2552206A4 (en) TRICYCLIC COMPOUNDS AND PBK INHIBITORS THEREWITH
ZA201208895B (en) Bicyclic compound derivatives and their use as acc inhibitors
ZA201300036B (en) Banzamide derivatives and their use as hsp90 inhibitors
HK1180726A1 (en) Kras primers and probes kras
HK1176675A1 (zh) 形成用於裝置中的增強表面壁的方法
HRP20150939T1 (xx) Derivati pirazola korisni kao inhibitori aldosteronske sintaze